サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：呼吸回路の世界市場-2023年～2030年
市場調査レポート
商品コード
1345406

呼吸回路の世界市場-2023年～2030年

Global Breathing Circuits Market - 2023-2030

出版日
ページ情報
英文 186 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
呼吸回路の世界市場-2023年～2030年
出版日: 2023年09月06日
発行: DataM Intelligence
ページ情報: 英文 186 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

概要

世界の呼吸回路市場は、2022年に12億米ドルに達し、2023-2030年の予測期間にCAGR 4.4％で成長し、2030年には17億米ドルに達すると予測されています。

呼吸回路の望ましい特性には、ガスフローに対する抵抗が少ないこと、先行する呼気ガスの再呼吸が最小限であること、二酸化炭素が発生する速度で二酸化炭素を除去できること、必要に応じて供給ガス組成を迅速に変更できること、吸気ガスを加温加湿できること、廃ガスを安全に処理できることなどがあります。

呼吸回路の発展の歴史は、麻酔薬と技術の進歩と並行しています。現代の呼吸回路は、二酸化炭素吸収、バルブの位置、希釈新鮮ガスの使用などの特徴によって分類できます。呼吸回路の構成要素には、チューブ、バルブ、リザーバーバッグ、コネクター、最新の容積反射器などのデリバリーアセンブリが含まれます。

さらに、世界の呼吸回路は、いくつかの主要企業が、好ましい規制環境と慢性疾患に苦しむ増え続ける人口のために、世界中に製造施設を拡大しているような様々な要因によって駆動されます。呼吸機能障害の発生率の上昇も、呼吸回路の需要を押し上げる要因となっています。

ダイナミクス

呼吸器疾患の有病率の上昇

呼吸器疾患の有病率の増加は、予測期間中に市場が成長するための重要な要因の1つです。呼吸器系疾患の増加により、疾患範囲に応じた換気が必要となり、呼吸回路の使用が必要となるため、市場成長が見込まれます。

例えば、Centres for Disease Control and Preventionによると、COPDは推定2,000億人が罹患し、毎年32億人が死亡しており、世界的に死亡原因の第3位となっています。

喘息は最も一般的な非感染性疾患のひとつで、世界で2,620億人が罹患しています。2022年には22億人が新たに肺がんに罹患し、18億人が死亡すると予測されており、肺がんは世界のがん死亡の4人に1人を占めています。下気道感染症または肺炎は顕著な死因であり、主に中低所得国（LMICs）において毎年24億人以上の死亡者を出しています。COVID-19は世界中で肺炎による死亡者数を大幅に増加させています。

呼吸回路の技術進歩

呼吸回路の技術進歩は、予測期間中に市場が成長するための重要な要因の1つです。麻酔医療では最近、揮発性麻酔薬の直接注入、麻酔薬節約装置、赤外線低コスト分析器、閉鎖回路麻酔など、いくつかの進歩が起きています。

閉鎖回路システムは、麻酔供給システムの最新の改良点となっています。これらのシステムは、患者の酸素消費量と麻酔薬消費量の両方を合わせることによって機能するもので、新鮮ガス流量を一定に保ち、無駄なガスを掃気する従来の方法とは対照的です。

閉塞性睡眠時無呼吸症候群の有病率の上昇

閉塞性睡眠時無呼吸症候群の有病率の上昇は、予測期間中に市場を加速させる要因です。例えば、米国睡眠時無呼吸症候群協会によると、睡眠時無呼吸症候群は米国人だけでも180億人に蔓延しています。この統計は、米国人の約15人に1人、つまり米国の全人口の6.62％が睡眠時無呼吸症候群であることを示しています。カリフォルニア大学サンディエゴ校で行われた調査では、アフリカ系米国人54人と白人346人を対象に睡眠時無呼吸症候群の有無を調査しました。

その結果、アフリカ系米国人の被験者の17％が閉塞性睡眠時無呼吸症候群であったのに対し、白人では8％でした。これは、アフリカ系米国人は閉塞性睡眠時無呼吸症候群のリスクが高いという仮説を示しています。米国人全体の2～4パーセントが未診断の睡眠時無呼吸症候群です。これは約50人に1人が未診断であることを意味します。

ICUにおける呼吸回路の需要増加

ICUにおける呼吸回路の需要増加は、予測期間中に市場が成長する主な要因の1つです。呼吸回路は集中治療室で患者の呼吸プロセスを補助するために使用されます。これらの回路は機械式人工呼吸器に接続され、患者に酸素を供給し二酸化炭素を除去するために使用されます。呼吸回路の目的は、患者に調節された安全なガス流を供給する一方で、呼気や水分が人工呼吸器に到達する前に回収して感染を防ぐことです。それゆえ、呼吸回路は酸素を豊富に含む空気を患者の肺に送り込むと同時に、二酸化炭素を除去します。

製品回収

製品回収は、予測期間中の市場成長を妨げる要因の一つです。例えば、2023年5月、Draeger Medical社はSeattle PAP Plus、VentStarおよびその他の呼吸回路/麻酔キットをリコールしました。その結果、ウォータートラップ、Yピース、ホースコネクタを含む構成部品の一部または全部が外れる可能性があります。

これらの部品が緩んだり外れたりすると、呼吸回路が遮断され、酸素不足（低酸素症）または死亡を含む重度の傷害を引き起こす可能性があります。特に、新生児（新生児）を含む重症患者にとっては、傷害や死亡の危険性が大きいです。したがって、上記の要因は予測期間中の市場の成長を制限します。

また、病院、診療所、外来手術センター、在宅介護の現場での呼吸回路の使用は拡大を続けていますが、いくつかの問題が世界の市場拡大を抑制すると予想されます。一方向バルブや二酸化炭素の吸収増加により、患者が呼吸困難に陥る可能性があります。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • 呼吸器疾患の増加
      • 呼吸回路の技術進歩
      • 閉塞性睡眠時無呼吸症候群の増加
      • ICUにおける呼吸回路の需要増加
    • 抑制要因
      • 製品回収
    • 機会
      • 研究開発の増加
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析
  • ロシア・ウクライナ戦争の影響分析
  • DMIの見解

第6章 COVID-19分析

第7章 製品タイプ別

  • 開放型呼吸回路
  • 半開放型呼吸回路
  • 半閉鎖型呼吸システム
  • 閉鎖型呼吸回路

第8章 用途別

  • 麻酔
  • 呼吸機能障害
  • その他

第9章 エンドユーザー別

  • 病院
  • クリニック
  • 外来手術センター
  • その他

第10章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • ロシア
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋
  • 中東・アフリカ

第11章 競合情勢

  • 競合シナリオ
  • 市況/シェア分析
  • M&A分析

第12章 企業プロファイル

  • Medtronic plc
    • 企業概要
    • 製品ポートフォリオと説明
    • 財務概要
    • 主な動向
  • Ambu A/S
  • Flexicare Medical Ltd
  • Fisher & Paykel Healthcare Ltd
  • Dragerwerk AG & Co.
  • Hamilton Medical
  • Armstrong Medical Industries Inc
  • Meditera
  • GE Healthcare
  • Bio Med Devices

第13章 付録

目次
Product Code: MD6773

Overview

Global Breathing Circuits Market reached US$ 1.2 billion in 2022 and is expected to reach US$ 1.7 billion by 2030, growing with a CAGR of 4.4% during the forecast period 2023-2030.

The desirable characteristics of a breathing circuit include low resistance to gas flow, minimal rebreathing of the preceding exhaled gases, removal of carbon dioxide at the rate at which it is produced, rapid changes in delivered gas composition when required, warmed humidification of the inspired gases, and safe disposal of waste gases.

The history of the development of breathing circuits parallels advancements in anaesthetic agents and techniques. Modern breathing circuits can be classified according to characteristics such as carbon dioxide absorption, valve position, and the use of diluting fresh gases. The components of the breathing circuit include the tubing, valves, reservoir bag, connectors, and delivery assemblies such as the modern volume reflector.

Furthermore, the global breathing circuit is driven by various factors, like several key players are expanding their manufacturing facilities across the globe owing to a favourable regulatory environment and an ever, increasing population suffering from chronic ailments. The rising incidence of respiratory dysfunctions is also set to push the demand for breathing circuits.

Dynamics

Rise in the Prevalence of Respiratory Diseases

Increased prevalence of respiratory disease is one the key driver that helps the market to grow during the forecast period. Since rising in respiratory diseases, the need of ventilation is required according to the disease range indeed usage of breathing circuits is needed which indeed will increase the market growth.

For instance, according to the Centres for Disease Control and Prevention COPD affects an estimated 200 Billion people, with 3.2 Billion dying each year, making it the third-leading cause of mortality globally.

Asthma is one of the most common noncommunicable illnesses, impacting 262 Billion people worldwide. With almost 2.2 Billion new instances of lung cancer expected in 2022 and 1.80 Billion fatalities, lung cancer accounts for one in every four cancer deaths worldwide. Lower respiratory tract infection or pneumonia is a prominent cause of death, accounting for more than 2.4 Billion fatalities each year, primarily in low and middle-income countries (LMICs). COVID-19 has significantly increased pneumonia fatalities worldwide.

Technological Advancements in Breathing Circuits

Technological advancements in breathing circuits are one of the key factors that help the market to grow during the forecast period. Several advancements have happened in anaesthesia care recently, like Direct Injection of Volatile Anesthetics, Anesthetic Agent Conserving devices, Infrared Low-Cost analyzers, and Closed-Circuit Anesthesia.

Closed-circuit systems have become the newest improvement to anaesthesia delivery systems. These systems function by matching both the oxygen and anaesthetic agent consumption of the patient, as opposed to previous methods of having a constant low fresh gas flow and scavenging system for wasted gas.

Rise in the Prevalence of Obstructive Sleep Apnea

The rise in the prevalence of obstructive sleep apnea is the driver that helps the market to accelerate during the forecast period. For instance, according to the American Sleep apnea Association Sleep apnea is prevalent in as many as 18 Billion Americans alone. This statistic denotes that approximately 1 in every 15 Americans, or 6.62% of the total American population have a case of sleep apnea. Research conducted at the University of California's San Diego campus studied 54 African Americans and 346 Caucasians for the presence of sleep apnea.

The results showed that a full 17 per cent of African American test subjects had a case of obstructive sleep apnea present, compared to 8 per cent of the Caucasian subjects. This denotes a hypothesis that African Americans stand an increased risk of obstructive sleep apnea. Two to four per cent of all Americans have an undiagnosed case of sleep apnea. This accounts for approximately 1 in 50 individuals being undiagnosed.

Increase Demand for Breathing Circuits in ICU

Increase demand for breathing circuits in ICUs is one of the key factors that helps the market to grow during the forecast period. Breathing circuits are used in intensive care units to assist patients with their respiratory processes. These circuits are connected to mechanical ventilators, which are used to supply oxygen to the patient and remove carbon dioxide. The breathing circuit's objective is to provide the patient with a regulated and secure gas flow while preventing infection by collecting any exhaled air or moisture before it reaches the ventilator. Hence The breathing circuit allows oxygen-rich air to be delivered to the patient's lungs while also removing carbon dioxide.

Product Recall

Product recall is one of the factors that hamper the market growth during the forecast period. For instance, in May 2023 Draeger Medical recalled the Seattle PAP Plus as well as VentStar and other breathing circuit/anaesthesia kits after finding that glued connections may loosen before or during ventilation due to a manufacturing error. Partial or complete detachment of components including the water trap, y-piece, or hose connector, may occur as a result.

Loosening or detachment of these parts can interrupt the breathing circuit and may cause severe injury including lack of oxygen (hypoxia) or death. The risk of injury or death is especially great for critically ill patients including newborns (neonates). Thus the above factor will restrict the market from growing during the forecast period.

Also, while the use of breathing circuits in hospitals, clinics, ambulatory surgery centres and home care settings continues to expand, several issues are expected to restrain the expansion of the market globally. Patients may experience breathing difficulty due to unidirectional valves and increasing absorption of carbon dioxide.

Segment Analysis

The global breathing circuits market is segmented based on product type, application, end user and region.

The Hospitals Segment From The End User Segment Accounted for Approximately 43.1% of the Breathing Circuits Share

The hospitals segment from the end user segment accounted for 43.1% and it is expected to be dominated during the forecast period. Hospitals are anticipated to increasingly install breathing circuits owing to a rising number of agreements with several distributors, including local and regional firms. Moreover, the presence of advanced tertiary care settings in many countries is set to aid growth. Hospitals nowadays are also striving to provide comprehensive care to patients to push the adoption of breathing circuits globally, which would drive the segment.

For instance, in December 2022, ABM Respiratory Care, a medical technology company focused on developing and globally commercializing novel integrated airway clearance and ventilation solutions, announced the U.S. Food and Drug Administration (FDA) 510(k) clearance of the BiWaze Clear System. This new airway clearance system helps patients clear their airways as well as prevent or treat atelectasis by using Oscillating Lung Expansion (OLE) therapy. BiWaze® Clear can be used to treat both acute and chronic respiratory conditions in the hospital, long-term care and home environments.

Geographical Penetration

North America Accounted for Approximately 37.9% of the Market Share

North America is estimated to hold about 37.9% of the total market share throughout the forecast period, owing to the significant presence of major market players, flourishing healthcare facilities and increasing hospitalization rates for patients with respiratory diseases.

For instance, in October 2022 Medtronic plc a global leader in healthcare technology stated that company separated its combined patient monitoring and respiratory interventions businesses ("NewCo"), which are part of the company's Medical Surgical Portfolio previously. The Respiratory Interventions technology portfolio includes Puritan Bennett ventilators, Shiley airway portfolio, McGrath MAC video laryngoscopy, DAR breathing systems, as well as PAV+, NIV+ and IE Sync ventilation software solutions designed to improve workflow and care delivery.

Furthermore, in October 2021, ARMSTRONG MEDICAL launched Aqua VENT VT heated ventilator breathing circuits. These breathing circuits are used in critical care settings for mechanical life support ventilation and have been engineered to maintain humidity within the breathing circuits in a simple manner.

Competitive Landscape

The major global players in the market include: Medtronic plc, Ambu A/S, Flexicare Medical Ltd, Fisher & Paykel Healthcare Ltd, Dragerwerk AG & Co, Hamilton Medical, Armstrong Medical Industries Inc, Meditera, GE Healthcare, Bio-Med Devices and among others.

COVID-19 Impact Analysis

The COVID-19 epidemic has impacted the economies of diverse countries throughout the world in three ways: directly influencing output and demand; disrupting distribution systems; and having a financial impact on corporations and financial markets. Several nations, including Thailand, Indonesia, and Singapore, are experiencing transportation and distribution issues for healthcare items.

During the COVID-19 pandemic, there was an upsurge in demand for ventilators due to their usage in COVID-19 treatment, however, there was a scarcity of ventilators. For instance, on August 26, 2022, the United States Food and Drug Administration (FDA) issued an update about a medical equipment shortage caused by the COVID-19 pandemic. The device shortage list included categories such as dialysis-related items, personal protective equipment, testing supplies and equipment, and ventilation-related products.

By Product

  • Open Breathing Circuits
  • Semi Open Breathing Circuits
  • Semi-closed breathing systems
  • Closed Breathing Circuits

By Application

  • Anaesthesia
  • Respiratory Dysfunction
  • Others

By End user

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa

Key Developments

  • In November 2022, Xplore Health Technologies launched 'Airofit Pro' the world's first smart respiratory device which cost Rs. 34,990. The newly launched 'Airofit Pro' is a respiratory muscle training device.
  • In August 2022, Dragerwerk AG & Co. KGaA launched the Drager BG ProAir, a closed-circuit breathing device including innovative features to safeguard firemen participating in long-duration deployments, such as those in complex structures, tall buildings, tunnels, and basements.
  • In January 2022, Armstrong Medical launched its state-of-the-art heated breathing circuit technology, 'AquaVENT VT', in the Middle Eastern market. Armstrong Medical's state-of-the-art AquaVENT VT ventilator circuits manage humidity throughout the entire ventilator breathing circuit, meaning healthcare providers can focus their time on caring for their patients.

DMI Opinion

Overall, the global breathing circuit market has significant growth in future due to many factors Demand for breathing circuits will remain robust, offsetting any industry margin compression. Several key players are expanding their manufacturing facilities across the globe owing to a favourable regulatory environment and an ever, increasing population suffering from chronic ailments. The rising incidence of respiratory dysfunctions is also set to push the demand for breathing circuits. Hence also in the future upcoming innovations in the ventilation system and a rise in research and development will help the breathing circuit market to accelerate in future with utmost advancements.

Why Purchase the Report?

  • To visualize the global breathing circuits market segmentation based on product type, application, end user and region as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of global breathing circuits market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global breathing circuits market report would provide approximately 61 tables, 58 figures and 186 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product
  • 3.2. Snippet by Application
  • 3.3. Snippet by End User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rise in the Prevalence of Respiratory Diseases
      • 4.1.1.2. Technological Advancements in Breathing Circuits
      • 4.1.1.3. Rise in the Prevalence of Obstructive Sleep Apnea
      • 4.1.1.4. Increase Demand for Breathing Circuits in ICU
    • 4.1.2. Restraints
      • 4.1.2.1. Product Recall
    • 4.1.3. Opportunity
      • 4.1.3.1. Rise in Research and Developments
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Russia-Ukraine War Impact Analysis
  • 5.6. DMI Opinion

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID
    • 6.1.2. Scenario During COVID
    • 6.1.3. Scenario Post COVID
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Open Breathing Circuits*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Semi Open Breathing Circuits
  • 7.4. Semi-closed breathing systems
  • 7.5. Closed Breathing Circuits

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Anesthesia*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Respiratory Dysfunction
  • 8.4. Others

9. By End User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.1.2. Market Attractiveness Index, By End User
  • 9.2. Hospitals*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Clinics
  • 9.4. Ambulatory Surgical Centers
  • 9.5. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. UK
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Russia
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Medtronic plc*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Ambu A/S
  • 12.3. Flexicare Medical Ltd
  • 12.4. Fisher & Paykel Healthcare Ltd
  • 12.5. Dragerwerk AG & Co.
  • 12.6. Hamilton Medical
  • 12.7. Armstrong Medical Industries Inc
  • 12.8. Meditera
  • 12.9. GE Healthcare
  • 12.10. Bio Med Devices

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us